Completed PHASE3 INTERVENTIONAL 2-arm NCT04579419

Injection Site Pain Botulinum Toxin Reconstituted in NS With and Without Sodium Bicarbonate

Injection Site Pain, Onset and Duration of Action of Botulinum Toxin Reconstituted in Normal Saline With and Without Sodium Bicarbonate; A Prospective, Single Center, Randomized, Double-Blind Interventional Study

Sponsor: King Abdulaziz Medical City

Conditions Wrinkle

Interventions Normal Saline Sodium Bicarbonate

Updated 4 times since 2020 Last updated: Oct 2, 2020 Started: Nov 9, 2019 Primary completion: Aug 9, 2020 Completion: Aug 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Wrinkle and is currently completed. King Abdulaziz Medical City leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2020 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Abdulaziz Medical City

Data source: King Abdulaziz Medical City

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riyadh, Saudi Arabia